These findings suggested that TBC1D23 interacted with Rab11A through the TBC1 domain, thereby activating the β1 integrin/FAK/ERK signalling pathway, ultimately promoting the proliferation, migration and invasion of NSCLC cells. The gene discussed is PTK2; the disease is non-small cell lung carcinoma.